Agency Business briefs: November 2012

Share this article:
Shellie Winkler
Shellie Winkler

McCann Healthcare promoted James Hammond to the new position of chief strategy officer for China and Japan operations. Hammond, formerly president of McCann Healthcare China, brings more than 20 years of healthcare agency experience, including senior roles at Publicis, DDB and McCann in Asian markets.

MSLGroup North America named Shellie Winkler s head of its health and corporate practices. Winkler joins from Edelman, where she was general manager of corporate and public affairs operations for the New York office. MSLGroup North America clients include Lilly, Bayer, Trius Therapeutics and Shriners Hospitals for Children.

Given Imaging tapped Rochester agency Martino Flynn to handle its advertising and PR business. Given Imaging makes gastrointestinal and digestive medical devices, including recently-launched PillCam SB, offered as a diagnostic tool for Crohn's Disease.

Management consulting firm Navigant has acquired Easton Associates. thereby giving it a presence in Beijing while adding capabilities to its operations in New York, Chicago and London and boosting its staff to 90.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?